Tumor cell- and microenvironment-specific roles of cysteine cathepsins in mouse models of human cancers

Schröder, 2010, The proteome of lysosomes, Proteomics, 10, 4053, 10.1002/pmic.201000196 Turk, 2012, Cysteine cathepsins: from structure, function and regulation to new frontiers, Biochim. Biophys. Acta, Proteins Proteomics, 1824, 68, 10.1016/j.bbapap.2011.10.002 Mason, 2008, Emerging functions of placental cathepsins, Placenta, 29, 385, 10.1016/j.placenta.2008.02.006 Reiser, 2010, Specialized roles for cysteine cathepsins in health and disease, J. Clin. Invest., 120, 3421, 10.1172/JCI42918 Mohamed, 2006, Cysteine cathepsins: multifunctional enzymes in cancer, Nat. Rev. Cancer, 6, 764, 10.1038/nrc1949 Olson, 2015, Cysteine cathepsin proteases: regulators of cancer progression and therapeutic response, Nat. Rev. Cancer, 15, 712, 10.1038/nrc4027 Elie, 2010, Identification and pre-clinical testing of a reversible cathepsin protease inhibitor reveals anti-tumor efficacy in a pancreatic cancer model, Biochimie, 92, 1618, 10.1016/j.biochi.2010.04.023 Shree, 2011, Macrophages and cathepsin proteases blunt chemotherapeutic response in breast cancer, Genes Dev., 25, 2465, 10.1101/gad.180331.111 Schurigt, 2008, Trial of the cysteine cathepsin inhibitor JPM-OEt on early and advanced mammary cancer stages in the MMTV-PyMT-transgenic mouse model, Biol. Chem., 389, 10.1515/BC.2008.115 Joyce, 2004, Multiple roles for cysteine cathepsins in cancer, Cell Cycle, 3, 1516, 10.4161/cc.3.12.1289 Kersten, 2017, Genetically engineered mouse models in oncology research and cancer medicine, EMBO Mol. Med., 9, 10.15252/emmm.201606857 Hanahan, 2007, The origins of oncomice: a history of the first transgenic mice genetically engineered to develop cancer, Genes Dev., 21, 2258, 10.1101/gad.1583307 Walsh, 2017, Humanized mouse models of clinical disease, Annu. Rev. Pathol. Mech. Dis., 12, 187, 10.1146/annurev-pathol-052016-100332 Sflomos, 2016, A preclinical model for erα-positive breast cancer points to the epithelial microenvironment as determinant of luminal phenotype and hormone response, Cancer Cell, 29, 407, 10.1016/j.ccell.2016.02.002 Gopinath, 2013, Cathepsin B and uPAR regulate self-renewal of glioma-initiating cells through GLI-regulated Sox2 and Bmi1 expression, Carcinogenesis, 34, 550, 10.1093/carcin/bgs375 Nalla, 2010, Targeting MMP-9, uPAR, and cathepsin B inhibits invasion, migration and activates apoptosis in prostate cancer cells, Cancer Gene Ther., 17, 599, 10.1038/cgt.2010.16 Hanahan, 1985, Heritable formation of pancreatic β-cell tumours in transgenic mice expressing recombinant insulin/simian virus 40 oncogenes, Nature, 315, 115, 10.1038/315115a0 Christofori, 1994, A second signal supplied by insulin-like growth factor II in oncogene-induced tumorigenesis, Nature, 369, 414, 10.1038/369414a0 Joyce, 2004, Cathepsin cysteine proteases are effectors of invasive growth and angiogenesis during multistage tumorigenesis, Cancer Cell, 5, 443, 10.1016/S1535-6108(04)00111-4 Akkari, 2014, Distinct functions of macrophage-derived and cancer cell-derived cathepsin Z combine to promote tumor malignancy via interactions with the extracellular matrix, Genes Dev., 28, 2134, 10.1101/gad.249599.114 Akkari, 2016, Combined deletion of cathepsin protease family members reveals compensatory mechanisms in cancer, Genes Dev., 30, 220, 10.1101/gad.270439.115 Gocheva, 2010, Deletion of cathepsin H perturbs angiogenic switching, vascularization and growth of tumors in a mouse model of pancreatic islet cell cancer, Biol. Chem., 391, 937, 10.1515/bc.2010.080 Gocheva, 2006, Distinct roles for cysteine cathepsin genes in multistage tumorigenesis, Genes Dev., 20, 543, 10.1101/gad.1407406 Wang, 2006, Cathepsin S controls angiogenesis and tumor growth via Matrix-derived angiogenic factors, J. Biol. Chem., 281, 6020, 10.1074/jbc.M509134200 Chiaravalli, 2017, Pancreatic ductal adenocarcinoma: State-of-the-art 2017 and new therapeutic strategies, Cancer Treat. Rev., 60, 32, 10.1016/j.ctrv.2017.08.007 Hingorani, 2005, Trp53R172H and KrasG12D cooperate to promote chromosomal instability and widely metastatic pancreatic ductal adenocarcinoma in mice, Cancer Cell, 7, 469, 10.1016/j.ccr.2005.04.023 Gopinathan, 2012, Cathepsin B promotes the progression of pancreatic ductal adenocarcinoma in mice, Gut, 61, 877, 10.1136/gutjnl-2011-300850 Felbor, 2000, Secreted cathepsin L generates endostatin from collagen XVIII, EMBO J., 19, 1187, 10.1093/emboj/19.6.1187 Urbich, 2005, Cathepsin L is required for endothelial progenitor cell–induced neovascularization, Nat. Med., 11, 206, 10.1038/nm1182 Brindle, 2015, Deficiency for the cysteine protease Cathepsin L Impairs Myc-Induced tumorigenesis in a mouse model of pancreatic neuroendocrine cancer, PLoS One, 10, 10.1371/journal.pone.0120348 Poole, 1978, Differences in secretion of the proteinase cathepsin B at the edges of human breast carcinomas and fibroadenomas, Nature, 273, 545, 10.1038/273545a0 Aggarwal, 2014, Cathepsin B: multiple roles in cancer, Proteomics Clin. Appl., 8, 427, 10.1002/prca.201300105 Guy, 1992, Induction of mammary tumors by expression of polyomavirus middle T oncogene: a transgenic mouse model for metastatic disease, Mol. Cell. Biol., 12, 954, 10.1128/MCB.12.3.954 Cheng, 2009, Cellular transformation by Simian Virus 40 and Murine Polyoma Virus T antigens, Semin. Cancer Biol., 19, 218, 10.1016/j.semcancer.2009.03.002 Zhang, 2017, A pan-cancer proteogenomic atlas of PI3K/AKT/mTOR pathway alterations, Cancer Cell, 31, 820, 10.1016/j.ccell.2017.04.013 Lin, 2003, Progression to malignancy in the polyoma middle T oncoprotein mouse breast cancer model provides a reliable model for human diseases, Am. J. Pathol., 163, 2113, 10.1016/S0002-9440(10)63568-7 Vasiljeva, 2006, Tumor cell-derived and macrophage-derived cathepsin B promotes progression and lung metastasis of mammary cancer, Cancer Res., 66, 5242, 10.1158/0008-5472.CAN-05-4463 Vasiljeva, 2008, Reduced tumour cell proliferation and delayed development of high-grade mammary carcinomas in cathepsin B-deficient mice, Oncogene, 27, 4191, 10.1038/onc.2008.59 Sevenich, 2010, Synergistic antitumor effects of combined cathepsin B and cathepsin Z deficiencies on breast cancer progression and metastasis in mice, Proc. Natl. Acad. Sci., 107, 2497, 10.1073/pnas.0907240107 Ruffell, 2013, Cathepsin C is a tissue-specific regulator of squamous carcinogenesis, Genes Dev., 27, 2086, 10.1101/gad.224899.113 Toss, 2020, Prognostic significance of cathepsin v (CTSV/CTSL2) in breast ductal carcinoma in situ, J. Clin. Pathol., 73, 76, 10.1136/jclinpath-2019-205939 Gautam, 2017, Up-regulation of cathepsin S expression by HSP90 and 5-HT7 receptor-dependent serotonin signaling correlates with triple negativity of human breast cancer, Breast Cancer Res. Treat., 161, 29, 10.1007/s10549-016-4027-1 Nouh, 2011, Cathepsin B: a potential prognostic marker for inflammatory breast cancer, J. Transl. Med., 9, 1, 10.1186/1479-5876-9-1 Sevenich, 2011, Transgenic expression of human cathepsin B promotes progression and metastasis of polyoma-middle-T-induced breast cancer in mice, Oncogene, 30, 54, 10.1038/onc.2010.387 Bengsch, 2014, Cell type-dependent pathogenic functions of overexpressed human cathepsin B in murine breast cancer progression, Oncogene, 33, 4474, 10.1038/onc.2013.395 Tholen, 2015, Stress-resistant translation of Cathepsin L mRNA in breast cancer progression, J. Biol. Chem., 290, 15758, 10.1074/jbc.M114.624353 Abrahamson, 2003, Cystatins, Biochem. Soc. Symp., 179 Breznik, 2019, Cystatins in cancer progression: more than just cathepsin inhibitors, Biochimie, 166, 233, 10.1016/j.biochi.2019.05.002 Butinar, 2014, Stefin B deficiency reduces tumor growth via sensitization of tumor cells to oxidative stress in a breast cancer model, Oncogene, 33, 3392, 10.1038/onc.2013.314 Završnik, 2017, Cystatin C deficiency suppresses tumor growth in a breast cancer model through decreased proliferation of tumor cells, Oncotarget, 8, 73793, 10.18632/oncotarget.17379 Arbeit, 1994, Progressive squamous epithelial neoplasia in K14-human papillomavirus type 16 transgenic mice, J. Virol., 68, 4358, 10.1128/JVI.68.7.4358-4368.1994 Yu, 2010, Cystatin C deficiency promotes epidermal dysplasia in K14-HPV16 transgenic mice, PLoS One, 5, 10.1371/journal.pone.0013973 Dennemärker, 2010, Deficiency for the cysteine protease cathepsin L promotes tumor progression in mouse epidermis, Oncogene, 29, 1611, 10.1038/onc.2009.466 Reinheckel, 2005, The lysosomal cysteine protease cathepsin L regulates keratinocyte proliferation by control of growth factor recycling, J. Cell Sci., 118, 3387, 10.1242/jcs.02469 DiGiovanni, 1992, Multistage carcinogenesis in mouse skin, Pharmacol. Ther., 54, 63, 10.1016/0163-7258(92)90051-Z Benavides, 1999, Nackt (nkt), a new hair loss mutation of the mouse with associated CD4 deficiency, Immunogenetics, 49, 413, 10.1007/s002510050514 Benavides, 2012, Protective role of cathepsin L in mouse skin carcinogenesis, Mol. Carcinog., 51, 352, 10.1002/mc.20792 Roth, 2000, Cathepsin L deficiency as molecular defect of furless: hyperproliferation of keratinocytes and pertubation of hair follicle cycling, FASEB J., 14, 2075, 10.1096/fj.99-0970com Moser, 1995, ApcMin: a mouse model for intestinal and mammary tumorigenesis, Eur. J. Cancer, 31, 1061, 10.1016/0959-8049(95)00181-H Boudreau, 2007, Loss of cathepsin L activity promotes claudin-1 overexpression and intestinal neoplasia, FASEB J., 21, 3853, 10.1096/fj.07-8113com Ziegler, 2018, Mitophagy in intestinal epithelial cells triggers adaptive immunity during tumorigenesis, Cell, 174, 88, 10.1016/j.cell.2018.05.028 Sudhan, 2015, Cathepsin L targeting in cancer treatment, Pharmacol. Ther., 155, 105, 10.1016/j.pharmthera.2015.08.007 Mehanna, 2016, Cathepsin D in pancreatic acinar cells is implicated in cathepsin B and L degradation, but not in autophagic activity, Biochem. Biophys. Res. Commun., 469, 405, 10.1016/j.bbrc.2015.12.002 Ketscher, 2016, Neuroectoderm-specific deletion of cathepsin D in mice models human inherited neuronal ceroid lipofuscinosis type 10, Biochimie, 122, 219, 10.1016/j.biochi.2015.07.020 Lotinun, 2013, Osteoclast-specific cathepsin K deletion stimulates S1P-dependent bone formation, J. Clin. Invest., 123, 666 Joyce, 2009, Microenvironmental regulation of metastasis, Nat. Rev. Cancer, 9, 239, 10.1038/nrc2618 Liotta, 2001, The microenvironment of the tumour - Host interface, Nature, 411, 375, 10.1038/35077241 Hanahan, 2012, Accessories to the crime: functions of cells recruited to the tumor microenvironment, Cancer Cell, 21, 309, 10.1016/j.ccr.2012.02.022 Pollard, 2004, Tumour-educated macrophages promote tumour progression and metastasis, Nat. Rev. Cancer, 4, 71, 10.1038/nrc1256 Bissell, 2002, The organizing principle: microenvironmental influences in the normal and malignant breast, Differentiation, 70, 537, 10.1046/j.1432-0436.2002.700907.x Emon, 2018, Biophysics of tumor microenvironment and cancer metastasis - a mini review, Comput. Struct. Biotechnol. J., 16, 279, 10.1016/j.csbj.2018.07.003 Hanahan, 2011, Hallmarks of cancer: the next generation, Cell., 144, 646, 10.1016/j.cell.2011.02.013 Gocheva, 2010, IL-4 induces cathepsin protease activity in tumor-associated macrophages to promote cancer growth and invasion, Genes Dev., 24, 241, 10.1101/gad.1874010 Linebaugh, 1999, Exocytosis of active cathepsin B: Enzyme activity at pH 7.0, inhibition and molecular mass, Eur. J. Biochem., 264, 100, 10.1046/j.1432-1327.1999.00582.x Sevenich, 2014, Analysis of tumour- and stroma-supplied proteolytic networks reveals a brain-metastasis-promoting role for cathepsin S, Nat. Cell Biol., 16, 876, 10.1038/ncb3011 Withana, 2012, Cathepsin B inhibition limits bone metastasis in breast cancer, Cancer Res., 72, 1199, 10.1158/0008-5472.CAN-11-2759 Verbovšek, 2015, Complexity of cancer protease biology: Cathepsin K expression and function in cancer progression, Semin. Cancer Biol., 35, 71, 10.1016/j.semcancer.2015.08.010 Brömme, 2016, Cathepsin K osteoporosis trials, pycnodysostosis and mouse deficiency models: commonalities and differences, Expert Opin. Drug Discovery, 11, 457, 10.1517/17460441.2016.1160884 Herroon, 2013, Macrophage cathepsin K promotes prostate tumor progression in bone, Oncogene, 32, 1580, 10.1038/onc.2012.166 Liang, 2019, Targeting cathepsin K diminishes prostate cancer establishment and growth in murine bone, J. Cancer Res. Clin. Oncol., 145, 1999, 10.1007/s00432-019-02950-y Mikhaylov, 2011, Ferri-liposomes as an MRI-visible drug-delivery system for targeting tumours and their microenvironment, Nat. Nanotechnol., 6, 594, 10.1038/nnano.2011.112 Krueger, 2013, Induction of premalignant host responses by cathepsin x/z-deficiency in helicobacter pylori-infected mice, PLoS One, 8, 10.1371/journal.pone.0070242 Yang, 2014, Cathepsin S-mediated autophagic flux in tumor-associated macrophages accelerate tumor development by promoting M2 polarization, Mol. Cancer, 13, 1, 10.1186/1476-4598-13-43 Small, 2013, Cathepsin S from both tumor and tumor-associated cells promote cancer growth and neovascularization, Int. J. Cancer, 133, 2102, 10.1002/ijc.28238 Reinheckel, 2017, New kid on the block, Theranostics, 7, 2965, 10.7150/thno.21603 Ballabio, 2020, Lysosomes as dynamic regulators of cell and organismal homeostasis, Nat. Rev. Mol. Cell Biol., 21, 101, 10.1038/s41580-019-0185-4 Aits, 2013, Lysosomal cell death at a glance, J. Cell Sci., 126, 1905, 10.1242/jcs.091181 Ewald, 2011, Nucleic acid recognition by Toll-like receptors is coupled to stepwise processing by cathepsins and asparagine endopeptidase, J. Exp. Med., 208, 643, 10.1084/jem.20100682 Vasiljeva, 2008, Dual contrasting roles of cysteine cathepsins in cancer progression: apoptosis versus tumour invasion, Biochimie, 90, 380, 10.1016/j.biochi.2007.10.004 Hämälistö, 2020, Spatially and temporally defined lysosomal leakage facilitates mitotic chromosome segregation, Nat. Commun., 11, 229, 10.1038/s41467-019-14009-0 Brojatsch, 2015, Distinct cathepsins control necrotic cell death mediated by pyroptosis inducers and lysosome-destabilizing agents, Cell Cycle, 14, 964, 10.4161/15384101.2014.991194 Halle, 2008, The NALP3 inflammasome is involved in the innate immune response to amyloid-beta, Nat. Immunol., 9, 857, 10.1038/ni.1636 Brix, 2008, Cysteine cathepsins: cellular roadmap to different functions, Biochimie, 90, 194, 10.1016/j.biochi.2007.07.024 Bratovš, 2019, Stefin A-functionalized liposomes as a system for cathepsins S and L-targeted drug delivery, Biochimie, 166, 94, 10.1016/j.biochi.2019.05.018 Mikhaylov, 2014, Selective targeting of tumor and stromal cells by a nanocarrier system displaying lipidated cathepsin b inhibitor, Angew. Chem. Int. Ed., 53, 10077, 10.1002/anie.201402305 Rothberg, 2013, Acid-mediated tumor proteolysis: contribution of cysteine cathepsins, Neoplasia, 15, 1125, 10.1593/neo.13946 Kramer, 2017, Non-invasive in vivo imaging of tumour-associated cathepsin B by a highly selective inhibitory DARPin, Theranostics, 7, 2806, 10.7150/thno.19081 Kwok, 2011, Antibody targeting of Cathepsin S induces antibody-dependent cellular cytotoxicity, Mol. Cancer, 10, 147, 10.1186/1476-4598-10-147 Wartenberg, 2019, Imaging of extracellular cathepsin S activity by a selective near infrared fluorescence substrate-based probe, Biochimie, 166, 84, 10.1016/j.biochi.2019.03.013